We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. A robust walking detection algorithm using a single foot-worn inertial sensor: validation in real-life settings

    Walking activity and gait parameters are considered among the most relevant mobility-related parameters. Currently, gait assessments have been mainly...

    Gaëlle Prigent, Kamiar Aminian, ... Anisoara Paraschiv-Ionescu in Medical & Biological Engineering & Computing
    Article Open access 18 April 2023
  2. Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group

    Next-Generation Sequencing is needed for the accurate genetic risk stratification of acute myeloid leukemia according to European LeukemiaNet (ELN)...

    Claudia Sargas, Rosa Ayala, ... Esther Prados de la Torre in Blood Cancer Journal
    Article Open access 12 May 2023
  3. Clinical outcome predictors for metastatic renal cell carcinoma: a retrospective multicenter real-life case series

    Over the last decades, the therapeutic armamentarium of metastatic renal cell carcinoma (mRCC) has been revolutionized by the advent of...

    Mimma Rizzo, Gaetano Pezzicoli, ... Silvana Quaglini in BMC Cancer
    Article Open access 05 July 2024
  4. Exposure–Response Analyses of Olaparib in Real-Life Patients with Ovarian Cancer

    Background

    Olaparib is given in a fixed dose of twice-daily 300 mg in patients who are diagnosed with ovarian cancer, breast cancer, prostate cancer...

    Ma Ida Mohmaed Ali, Maaike A. C. Bruin, ... Alwin D. R. Huitema in Pharmaceutical Research
    Article 22 March 2023
  5. Insights for clinical management from the real-life data of the centralized West of Scotland biliary cancer clinic

    Background

    With the increasing of novel therapeutics for the treatment of Biliary Tract Cancers (BTC), and the need to assess their socio-economic...

    Valentina Zanuso, Tamsin Nash, ... Chiara Braconi in BMC Cancer
    Article Open access 16 May 2024
  6. Real life data on nintedanib safety: idiopathic pulmonary fibrosis versus systemic sclerosis-interstitial lung disease and strategies adopted to manage adverse effects

    Objective

    Nintedanib (NIN) is an antifibrotic drug approved to slow the progression of idiopathic pulmonary fibrosis (IPF) and systemic...

    Marco Di Battista, Laura Tavanti, ... Marta Mosca in Inflammopharmacology
    Article Open access 03 August 2023
  7. How does the human brain process noisy speech in real life? Insights from the second-person neuroscience perspective

    Comprehending speech with the existence of background noise is of great importance for human life. In the past decades, a large number of...

    Zhuoran Li, Dan Zhang in Cognitive Neurodynamics
    Article 05 January 2023
  8. Cardiovascular adverse events-related to GnRH agonists and GnRH antagonists: analysis of real-life data from Eudra-Vigilance and Food and Drug Administration databases entries

    Introduction and objectives

    GnRH agonists and GnRH antagonists are two of the mainstays of hormonal therapy (HT) for prostate cancer (PCa). These...

    Antonio Cicione, Antonio Nacchia, ... Cosimo De Nunzio in Prostate Cancer and Prostatic Diseases
    Article 14 January 2023
  9. Acute skin toxicity of conventional fractionated versus hypofractionated radiotherapy in breast cancer patients receiving regional node irradiation: the real-life prospective multicenter HYPOBREAST cohort

    Background

    Large-scale trials have shown that hypofractionated adjuvant breast radiotherapy was as effective in terms of survival and local control as...

    Marie Bruand, Julia Salleron, ... Jean-Christophe Faivre in BMC Cancer
    Article Open access 16 December 2022
  10. Evaluation of quality of life in lung cancer patients receiving radiation and Viscum album L.: a real-world data study

    Background

    Lung cancer (LC) is associated with high mortality and poor quality of life (QoL). The disease as well as oncological treatments such as...

    Friedemann Schad, Diana Steinmann, ... Christian Grah in Radiation Oncology
    Article Open access 06 March 2023
  11. The impact of locoregional treatments for metastatic castration resistant prostate cancer on disease progression: real life experience from a multicenter cohort

    Background

    Available data on medical treatment of metastatic castration resistant prostate cancer (mCRPC) support the use of more than one therapy...

    Mariaconsiglia Ferriero, Francesco Prata, ... Giuseppe Simone in Prostate Cancer and Prostatic Diseases
    Article 02 December 2022
  12. Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients

    Background

    Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment landscape of relapsed/refractory multiple myeloma (RRMM),...

    Dilara Akhoundova Sanoyan, Katja Seipel, ... Thomas Pabst in BMC Cancer
    Article Open access 15 April 2023
  13. Exposure–Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life Setting

    Background

    Osimertinib, an irreversible inhibitor of the epidermal growth factor receptor (EGFR) is an important drug in the treatment of...

    René J. Boosman, Merel Jebbink, ... Neeltje Steeghs in Pharmaceutical Research
    Article 17 August 2022
  14. Favorable safety profile of moderate hypofractionated over normofractionated radiotherapy in breast cancer patients: a multicentric prospective real-life data farming analysis

    Background

    Moderately hypofractionated whole-breast radiotherapy (HFRT) has proven to be as safe and efficient as normofractionated radiotherapy...

    Irfane Issoufaly, Claire Petit, ... Sofia Rivera in Radiation Oncology
    Article Open access 20 April 2022
  15. Monitoring of Adverse Events and Safety in Autoinflammatory Diseases: Real-Life Data from the Eurofever Registry

    Objectives

    The study is aimed to evaluate the impact of safety events in the Eurofever registry for Autoinflammatory diseases.

    Methods ...
    Yulia Vyzhga, Joost Frenkel, ... Marco Gattorno in Journal of Clinical Immunology
    Article 17 May 2024
  16. Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population

    Background

    Patients with pancreatic ductal adenocarcinoma (PDCA) carrying impaired mismatch repair mechanisms seem to have an outcome advantage under...

    Maria Cristina Sini, Maria Grazia Doro, ... Giuseppe Palmieri in Journal of Translational Medicine
    Article Open access 27 January 2024
  17. Intake of l-serine before bedtime prevents the delay of the circadian phase in real life

    Background

    It has been shown in laboratory experiments using human subjects that ingestion of the non-essential amino acid l -serine before bedtime...

    Michihiro Ohashi, Sang-il Lee, ... Shigekazu Higuchi in Journal of Physiological Anthropology
    Article Open access 26 August 2022
  18. Current perspectives in obesity management: unraveling the impact of different therapy approach in real life obesity care

    Background

    The challenge of addressing obesity persists in healthcare, necessitating nuanced approaches and personalized strategies. This study aims...

    Keyvan Khorrami Chokami, Amir Khorrami Chokami, ... Mara Boschetti in Journal of Translational Medicine
    Article Open access 06 June 2024
  19. Evaluation of power wheelchair driving performance in simulator compared to driving in real-life situations: the SIMADAPT (simulator ADAPT) project—a pilot study

    Objective

    The objective of this study was to evaluate users’ driving performances with a Power Wheelchair (PWC) driving simulator in comparison to the...

    Bastien Fraudet, Emilie Leblong, ... Philippe Gallien in Journal of NeuroEngineering and Rehabilitation
    Article Open access 23 April 2024
  20. Low- vs high-dose ARNI effects on clinical status, exercise performance and cardiac function in real-life HFrEF patients

    Purpose

    Only a few studies are available on dose-related effects of sacubitril/valsartan (angiotensin receptor neprilysin inhibition (ARNI)) in...

    Egle Corrado, Giuseppe Dattilo, ... Cesare de Gregorio in European Journal of Clinical Pharmacology
    Article 23 September 2021
Did you find what you were looking for? Share feedback.